183 related articles for article (PubMed ID: 20836674)
1. Chronic lymphocytic leukemia: planning for an aging population.
Gribben JG
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1389-94. PubMed ID: 20836674
[TBL] [Abstract][Full Text] [Related]
2. How I treat CLL up front.
Gribben JG
Blood; 2010 Jan; 115(2):187-97. PubMed ID: 19850738
[TBL] [Abstract][Full Text] [Related]
3. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
[TBL] [Abstract][Full Text] [Related]
4. Management of elderly and unfit patients with chronic lymphocytic leukemia.
Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
[TBL] [Abstract][Full Text] [Related]
5. Update in the management of chronic lymphocytic leukemia.
Maddocks KJ; Lin TS
J Hematol Oncol; 2009 Jul; 2():29. PubMed ID: 19619273
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia.
Rai KR
J Hematol Oncol; 2015 Jul; 8():85. PubMed ID: 26170206
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
Kabadi SM; Goyal RK; Nagar SP; Kaye JA; Davis KL
Cancer Med; 2019 Jul; 8(8):3803-3810. PubMed ID: 31144473
[TBL] [Abstract][Full Text] [Related]
8. Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada.
Lee LJ; Toze CL; Huang SJT; Gillan TL; Connors JM; Sehn LH; Bruyere H; Leitch H; Ramadan KM; Gerrie AS
Leuk Lymphoma; 2018 Jun; 59(6):1356-1363. PubMed ID: 29032719
[TBL] [Abstract][Full Text] [Related]
9. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
[TBL] [Abstract][Full Text] [Related]
10. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
[TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
[TBL] [Abstract][Full Text] [Related]
12. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
Al-Sawaf O; Bahlo J; Robrecht S; Fischer K; Herling CD; Hoechstetter M; Fink AM; von Tresckow J; Langerbeins P; Cramer P; Stilgenbauer S; Wendtner CM; Eichhorst B; Hallek M; Goede V
Br J Haematol; 2018 Dec; 183(5):727-735. PubMed ID: 30460980
[TBL] [Abstract][Full Text] [Related]
13. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations.
Soumerai JD; Ni A; Darif M; Londhe A; Xing G; Mun Y; Kay NE; Shanafelt TD; Rabe KG; Byrd JC; Chanan-Khan AA; Furman RR; Hillmen P; Jones J; Seymour JF; Sharman JP; Ferrante L; Mobasher M; Stark T; Reddy V; Dreiling LK; Bhargava P; Howes A; James DF; Zelenetz AD
Lancet Haematol; 2019 Jul; 6(7):e366-e374. PubMed ID: 31109827
[TBL] [Abstract][Full Text] [Related]
14. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
[TBL] [Abstract][Full Text] [Related]
15. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
Iovino L; Shadman M
Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
[TBL] [Abstract][Full Text] [Related]
16. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
Pinilla-Ibarz J; Emole J
Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
[TBL] [Abstract][Full Text] [Related]
17. Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
Nabhan C; Mato A; Flowers CR; Grinblatt DL; Lamanna N; Weiss MA; Davids MS; Swern AS; Bhushan S; Sullivan K; Flick ED; Kiselev P; Sharman JP
BMC Cancer; 2017 Mar; 17(1):198. PubMed ID: 28302090
[TBL] [Abstract][Full Text] [Related]
18. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach.
Balducci L; Dolan D
Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study.
Fink AM; Bahlo J; Robrecht S; Al-Sawaf O; Aldaoud A; Hebart H; Jentsch-Ullrich K; Dörfel S; Fischer K; Wendtner CM; Nösslinger T; Ghia P; Bosch F; Kater AP; Döhner H; Kneba M; Kreuzer KA; Tausch E; Stilgenbauer S; Ritgen M; Böttcher S; Eichhorst B; Hallek M
Lancet Haematol; 2017 Oct; 4(10):e475-e486. PubMed ID: 28916311
[TBL] [Abstract][Full Text] [Related]
20. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
